If you live in rural America, you might be facing a different set of health challenges than someone in a city. A recent look at national survey data found that adults in nonmetropolitan areas were twice as likely to have been diagnosed with chronic obstructive pulmonary disease (COPD), a serious lung condition, compared to those in metropolitan areas. The survey, which included U.S. adults, showed 8% of rural residents had COPD versus 4% of city dwellers. This is an observational snapshot from 2019—it shows an association, but it doesn't prove that living in a rural area causes COPD. The data can't tell us what's driving this difference, whether it's factors like air quality, smoking rates, access to healthcare, or something else entirely. It simply highlights where the burden of this chronic illness appears to be heavier.
US survey finds higher COPD prevalence in nonmetropolitan versus metropolitan areasWhy is COPD twice as common in rural America compared to cities?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note survey finding of higher reported COPD prevalence in nonmetropolitan US areas; association does not imply causation.
A 2019 US National Health Interview Survey, an observational survey report, analyzed data from adults aged 18 years and older. It compared the percentage of adults with diagnosed chronic obstructive pulmonary disease (COPD) by residence in nonmetropolitan versus metropolitan areas. The main finding was that the percentage with diagnosed COPD was higher among those living in nonmetropolitan areas (8%) than among those living in metropolitan areas (4%). The report did not provide absolute numbers, effect sizes, p-values, or confidence intervals for this comparison. No safety or tolerability data were reported, as this was a prevalence survey. Key limitations include the observational, cross-sectional nature of the data, which cannot establish causation or determine the direction of any association. The analysis did not report on statistical testing or adjust for potential confounders such as smoking history, occupational exposures, or access to healthcare, which may differ by urbanization level and influence COPD diagnosis rates. For clinical practice, this finding highlights a geographic disparity in reported COPD burden but does not inform specific management decisions. The association should be recognized as a descriptive population-level pattern requiring confirmation through studies that can better account for underlying risk factors.
What this means for you:
COPD is twice as common in rural areas, but we don't yet know why. More on Chronic Obstructive Pulmonary Disease
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
Digital health tools show mixed results for managing chronic diseases
Digital tools show promise for heart failure monitoring but lack consistent evidence for improving medication adherence or general diabetes …
New data shows that while digital tools like apps can help heart failure patients monitor their health, they may not improve medication habi…
Structured exercise improves 6-minute walk distance by 38.62 m in idiopathic pulmonary fibrosis
Structured exercise improves endurance for people with lung scarring
This systematic review and meta-analysis of 503 patients found that structured exercise, particularly mind-body integrated training, signifi…
Specific types of structured exercise can improve walking distance and breathing for people living with idiopathic pulmonary fibrosis.
IoT-assisted pulmonary rehabilitation protocol for moderate-to-severe stable COPD patients in single institution
New plan tests smart technology for managing chronic lung disease
This prospective, non-randomized controlled intervention study protocol outlines an IoT-assisted pulmonary rehabilitation program for 588 pa…
A new trial plans to see if smart devices and apps can help people with chronic lung disease manage their symptoms at home.
Higher preoperative NLR and SII show increased risk for postoperative pneumonia and pulmonary complications in lung and esophageal surgery
Blood inflammation markers linked to higher lung surgery infection risk
This systematic review and meta-analysis of 3,936 patients found that higher preoperative neutrophil-to-lymphocyte ratio and systemic immune…
A review of nearly 4,000 patients found that higher preoperative blood inflammation markers were linked to a greater chance of pneumonia and…
View Original Abstract ↓
In 2019, the percentage of adults aged ≥18 years with diagnosed chronic obstructive pulmonary disease (COPD) was higher among those living in nonmetropolitan areas (8%) than among those living in metropolitan areas (4%).
Real-world meta-analysis supports pembrolizumab for advanced NSCLC with high PD-L1
Real-world data confirms pembrolizumab offers long-term survival for advanced lung cancer patients
Related in Pulmonology & Critical Care
FDA Approves Provocholine (methacholine chloride) for Bronchial Airway Hyperreactivity Diagnosis
FDA approves new test to help diagnose asthma in certain patients
The FDA approved Provocholine (methacholine chloride) for diagnosing bronchial airway hyperreactivity in adults and children aged 5 years an…
The FDA approved Provocholine, a drug used in a breathing test to diagnose airway hyperreactivity in people aged 5 and older who may have as…
Tislelizumab plus chemotherapy improves survival in extensive-stage small cell lung cancer
Immunotherapy combo extends survival in small cell lung cancer
This phase 3 RCT evaluated tislelizumab plus chemotherapy versus placebo plus chemotherapy in previously untreated extensive-stage small cel…
Adding tislelizumab to chemo helped people with extensive-stage small cell lung cancer live 2 months longer, a phase 3 trial shows.
Lower PEEP may increase ventilator-free days in ventilated patients without ARDS
Lower breathing pressure settings showed modest benefits for some critically ill patients without lung injury
This Bayesian re-analysis of an RCT in 980 invasively ventilated critically ill patients without ARDS found that lower PEEP (0-5 cm H2O) com…
A re-analysis of data found that using the lowest safe breathing pressure might help some patients breathe easier. However, the overall bene…
Machine learning models show moderate accuracy predicting neoadjuvant immunotherapy response in NSCLC
Machine learning models predict how well lung cancer patients respond to immunotherapy
This systematic review and meta-analysis of 44 models found that machine learning predicts neoadjuvant immunotherapy response in resectable …
A new analysis of 44 models shows computer programs can guess which lung cancer patients will benefit from immunotherapy, though the study h…
From Other Specialties
Fibromyalgia as an oncology comorbidity increases symptom burden and impairs treatment adherence
Fibromyalgia makes managing cancer pain more difficult for patients
This systematic review of 11 studies examines fibromyalgia as a comorbidity in cancer patients. The findings indicate that fibromyalgia cont…
Patients with both fibromyalgia and cancer face higher symptom burdens and may stop life-saving treatments sooner due to intense, amplified …
Physical exam algorithm distinguishes benign anal masses, guides surgical decisions
New Clinical Algorithm Helps Identify Anal Masses and Prolapse
This narrative review proposes a clinical decision algorithm based on physical examination to differentiate benign lesions prolapsing throug…
Doctors can now use a specific physical examination guide to tell the difference between rectal prolapse, hemorrhoids, and other anal condit…
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Heterogeneous definitions and clinical inconsistencies currently hinder the accurate identification of treatment-resistant depression
New ways to define treatment resistant depression are emerging
This narrative review examines the phenotypic definition of treatment-resistant depression (TRD) and its associated biological correlates. T…
Doctors struggle to treat some types of depression because the current definition is inconsistent. New research looks at how biology and beh…